Results 11 to 20 of about 744 (148)

CNL and aCML Should Be Considered as a Single Entity Based on Molecular Profiles and Outcomes [PDF]

open access: yesBlood Advances, 2023
Abstract Chronic neutrophilic leukemia (CNL) and atypical chronic myeloid leukemia (aCML) are rare myeloid disorders that are challenging with regard to diagnosis and clinical management. To study the similarities and differences between these disorders, we undertook a multicenter international study of one of the largest case series ...
Nicholas Cross   +2 more
exaly   +9 more sources

PB2249: ATYPICAL CHRONIC MYELOID LEUKEMIA (ACML) AND AUTOIMMUNE DISEASE: REPORT OF TWO CASES. [PDF]

open access: yesHemaSphere, 2023
Caterina Tatarelli   +5 more
doaj   +3 more sources

A rare case of aCML associated with CNS involvement and with aggressive clinical course

open access: yesLeukemia Research Reports, 2023
The presence of neutrophilic leukocytosis may underlie a wide variety of diseases. Some rare causes of neutrophilia might be chronic neutrophilic leukemia (CNL) and myelodysplastic/myeloproliferative neoplasm with neutrophilia (MDS with neutrophilia ...
Dorela Lame   +7 more
doaj   +3 more sources

Adult <i>TWIST2</i>-high B-ALL confirms metabolic association but reveals molecular heterogeneity. [PDF]

open access: yesHemasphere
HemaSphere, Volume 10, Issue 6, June 2026.
Walter W, Ecker V, Kern W, Stengel A.
europepmc   +2 more sources

Single-cell transcriptional consequences of leukaemogenic SETBP1 mutations. [PDF]

open access: yesBr J Haematol
British Journal of Haematology, Volume 208, Issue 6, Page 2269-2274, June 2026.
Trinh MK   +15 more
europepmc   +2 more sources

Ascertainment Conditional Maximum Likelihood for Continuous Outcome Under Two-Phase Response-Selective Design. [PDF]

open access: yesStat Med
ABSTRACT Data collection procedures are often time‐consuming and expensive. An alternative to collecting full information from all subjects enrolled in a study is a two‐phase design: Variables that are inexpensive or easy to measure are obtained for the study population, and more specific, expensive, or hard‐to‐measure variables are collected only for ...
Amorim G   +4 more
europepmc   +2 more sources

Evaluation of a father and son with atypical chronic myeloid leukemia with SETBP1 mutations and a review of the literature [PDF]

open access: yesBrazilian Journal of Medical and Biological Research, 2015
We report the case of a father and son diagnosed with atypical chronic myeloid leukemia (aCML). Both patients harbored SETBP1 mutations, which are present in 24.3% of aCML patients.
L. Wang, F. Du, H.-M. Zhang, H.-X. Wang
doaj   +3 more sources

A Pediatric Case of Atypical Chronic Myeloid Leukemia with CSF3R Mutation Not Responding to Ruxolitinib, but Rescued by Allogeneic Transplantation

open access: yesClinical Pediatric Hematology-Oncology, 2021
Atypical chronic myeloid leukemia (aCML), BCR-ABL1-negative is a rare myeloid neoplasm, especially in pediatric patients. The mutations identified in aCML have overlapped with those of other myeloid neoplasms.
Yoon Jung Choi   +5 more
doaj   +1 more source

Introduction: special issue of selected papers of ACML 2013 [PDF]

open access: yesMachine Learning, 2015
The 5thAsianConference onMachine Learning (ACML2013)was held on 13–15November 2013, at the Australian National University, Canberra, Australia. ACML aims at providing a leading international forum for researchers inmachine learning and relatedfields to share their new ideas and achievements.
Cheng Soon Ong   +4 more
openaire   +2 more sources

Atypical Chronic Myelogenous Leukemia, BCR-ABL1 Negative: Diagnostic Criteria and Treatment Approaches

open access: yesFrontiers in Oncology, 2021
Atypical chronic myelogenous leukemia (aCML), BCR/ABL1 negative is a rare myelodysplastic/myeloproliferative neoplasm, usually manifested with hyperleukocytosis without monocytosis or basophilia, organomegaly, and marked dysgranulopoiesis. In this review,
Panagiotis T. Diamantopoulos   +1 more
doaj   +1 more source

Home - About - Disclaimer - Privacy